BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1579253)

  • 1. Spastic paraparesis associated with portal-systemic venous shunting due to congenital hepatic fibrosis.
    Demirci M; Tan E; Elibol B; Gedikoğlu G; Saribaş O
    Neurology; 1992 May; 42(5):983-5. PubMed ID: 1579253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial ammonia levels in cirrhosis are determined by systemic and hepatic hemodynamics, and by organ function: a quantitative modelling study.
    Noiret L; Baigent S; Jalan R
    Liver Int; 2014 Jul; 34(6):e45-55. PubMed ID: 24134128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare intrahepatic portacaval tubular shunt in a patient with spastic paraparesis.
    Ardic S; Deniz E; Arbatli M; Ardic FA; Aysun A
    Australas Radiol; 1997 May; 41(2):181-4. PubMed ID: 9153820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spastic paraparesis with cirrhosis of liver.
    Rab SM; Hussain SM
    Br J Clin Pract; 1985 Jun; 39(6):244-6. PubMed ID: 4041351
    [No Abstract]   [Full Text] [Related]  

  • 5. The kidneys in hepatic cirrhosis: victims of portal-systemic venous shunting (portal-systemic nephropathy).
    Sherlock S
    Gastroenterology; 1993 Mar; 104(3):931-4. PubMed ID: 8440445
    [No Abstract]   [Full Text] [Related]  

  • 6. Disappearance of hepatic encephalopathy and improvement of liver function after surgical treatment of portal-systemic shunt in a patient with liver cirrhosis.
    Moriya K; Kojima H; Matsumura M; Sakurai S; Imazu H; Uemura M; Honda H; Fukui H
    Hepatogastroenterology; 2003; 50(52):1128-32. PubMed ID: 12845996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis.
    Bosch J; Gomis R; Kravetz D; Casamitjana R; Terés J; Rivera F; Rodés J
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G206-12. PubMed ID: 6383074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic myelopathy: a rare complication of portacaval shunt.
    Mendoza G; Marti-Fàbregas J; Kulisevsky J; Escartín A
    Eur Neurol; 1994; 34(4):209-12. PubMed ID: 8082679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
    Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
    J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of visual evoked potentials to the diagnosis of isolated progressive paraparesis in the adult].
    Brudon F; Mauguière F
    Nouv Presse Med; 1982 Oct; 11(42):3117-20. PubMed ID: 7177826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
    Eisenburg J; Krumpoch B; Grunst J; Weinzierl M; Munte A; Schmidt S; Magerl W; Schauer S
    Fortschr Med; 1972 Aug; 90(24):837-48. PubMed ID: 4639347
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathology of portal hypertension in liver cirrhosis].
    Cervela LA
    Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
    [No Abstract]   [Full Text] [Related]  

  • 13. Spastic paraparesis associated with advanced liver cirrhosis: a condition obscure in terms of treatment and prognosis.
    Kaur J; Jesrani G; Gupta M; Lehl SS
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32513765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic myelopathy neurological complication of chronic liver disease: two case reports.
    Mhiri M; Ben Abdelwahed M; Dhiflaoui MA; Ben Dhia R; Gouta N; Jemni I; Baklouti R; Zakhama M; Gueddiche A; Loghmari MH; Ben Chaabene N; Safer L; Frih-Ayed M
    J Med Case Rep; 2024 Jun; 18(1):281. PubMed ID: 38880918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired portosystemic shunting in 2 cats secondary to congenital hepatic fibrosis.
    Zandvliet MM; Szatmári V; van den Ingh T; Rothuizen J
    J Vet Intern Med; 2005; 19(5):765-7. PubMed ID: 16231725
    [No Abstract]   [Full Text] [Related]  

  • 16. Small-diameter H-graft portacaval shunt reduces portal flow yet maintains effective hepatic blood flow.
    Zervos EE; Goode SE; Rosemurgy AS
    Am Surg; 1998 Jan; 64(1):71-5; discussion 75-6. PubMed ID: 9457041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema.
    Miquel M; Bartolí R; Odena G; Serafín A; Cabré E; Galan A; Barba I; Córdoba J; Planas R
    Liver Int; 2010 Aug; 30(7):979-87. PubMed ID: 20492509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic paraplegia.
    Mousseau R; Reynolds T
    Am J Gastroenterol; 1976 Oct; 66(4):343-8. PubMed ID: 998595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative changes of portal and arterial blood supply of the liver following porta-systemic shunting procedures (author's transl)].
    Brölsch C; Grün M; Neuhaus P; Andreczewski W
    Chir Forum Exp Klin Forsch; 1980; ():161-5. PubMed ID: 7389448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The portal circulatory characteristics of patients with esophageal and gastric varices in liver cirrhosis].
    Kotenko OG
    Klin Khir; 1998; (9-10):17-9. PubMed ID: 10050381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.